Results Snapshot
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Mar 2026 is 3.24% vs -10.63% in Mar 2025
Consolidate Net Profit
YoY Growth in quarter ended Mar 2026 is -36.11% vs 66.29% in Mar 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Mar 2026 is -23.51% vs -30.71% in Mar 2025
Interest
YoY Growth in quarter ended Mar 2026 is 0.00% vs 0.00% in Mar 2025
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Mar 2026 has fallen from Mar 2025
Compare Quarterly Results Of Kobayashi Pharmaceutical Co., Ltd. With
Quarterly - Net Sales
QoQ Growth in quarter ended Mar 2026 is -37.31% vs 24.83% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 3.24% vs -10.63% in Mar 2025
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Mar 2026 is 132.93% vs -186.37% in Dec 2025
YoY Growth in quarter ended Mar 2026 is -36.11% vs 66.29% in Mar 2025
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Mar 2026 is -36.56% vs -18.82% in Dec 2025
YoY Growth in quarter ended Mar 2026 is -23.51% vs -30.71% in Mar 2025
Quarterly - Interest
QoQ Growth in quarter ended Mar 2026 is -69.23% vs 333.33% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 0.00% vs 0.00% in Mar 2025
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Mar 2026 has fallen from Dec 2025
YoY Growth in quarter ended Mar 2026 has fallen from Mar 2025






